LEXX

LEXX

USD

Lexaria Bioscience Corp. Common Stock

$1.110+0.120 (12.121%)

リアルタイム価格

Healthcare
バイオテクノロジー
カナダ

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.990

高値

$1.137

安値

$0.990

出来高

0.17M

企業ファンダメンタルズ

時価総額

24.7M

業種

バイオテクノロジー

Canada

取引統計

平均出来高

0.57M

取引所

NCM

通貨

USD

52週レンジ

安値 $0.775現在値 $1.110高値 $2.85

関連ニュース

AccessWire

Lexaria Bioscience Corp. Provides Strategic Update

Strategic Business Development Advisory Firm Engaged To Support New Business Development ActivitiesLexaria Awarded 4 New Patents KELOWNA, BC / ACCESS Newswire / October 9, 2025 / Lexaria Bioscience Corp.

もっと見る
Lexaria Bioscience Corp. Provides Strategic Update
AccessWire

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / September 29, 2025 / Lexaria Bioscience Corp.

もっと見る
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
AccessWire

Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / September 26, 2025 / Lexaria Bioscience Corp. ) , a global innovator in drug delivery platforms, today announced that it

もっと見る
Lexaria Bioscience Corp. Announces $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
AccessWire

Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain

Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and Efficacy KELOWNA, BC / ACCESS Newswire / September 19, 2025 / Lexaria Bioscience Corp. (the

もっと見る
Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain